Biologics protect psoriasis patients from being exacerbated by COVID-19 infection
Description
CONCLUSIONS: This study provided new insights into the protective role of biological agents in patients with psoriasis who were infected with COVID-19, and we proposed that psoriatic patients treated with biologics should continue with the treatment
